REGISTERED
on 28 Nov 2023
Last Applicant/ Owned by
5 Radnor Corporate Center, Suite 500
Radnor
PA
19087
Serial Number
90232607 filed on 02th Oct 2020
Registration Number
7231187 registered on 28th Nov 2023
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
GAABRYDA
Pharmaceutical preparations for the treatment of seizures and epilepsy, status epilepticus, encephalopathies, neurodegenerative disease, cerebrovascular disease, movement disorders, traumatic brain injury and other neurologic conditions, substance abuse, substance withdrawal, dementia, delirium, schizophrenia, bipolar disorder, psychosis, depression, and other psychiatric conditions
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of seizures and epilepsy, status epilepticus, encephalopathies, neurodegenerative disease, cerebrovascular disease, movement disorders, traumatic brain injury and other neurologic conditions, substance abuse, substance withdrawal, dementia, delirium, schizophrenia, bipolar disorder, psychosis, depression, and other psychiatric conditions
First Use Date in General
15th Sep 2023
First Use Date in Commerce
15th Sep 2023
Mark Details
Serial Number
No 90232607
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 506890006001
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 28th Nov 2023 | REGISTERED-PRINCIPAL REGISTER |
| 28th Nov 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 27th Oct 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 26th Oct 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 12th Oct 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 10th Oct 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 28th Sep 2023 | TEAS STATEMENT OF USE RECEIVED |
| 28th Sep 2023 | USE AMENDMENT FILED |
| 02th Jun 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 31st May 2023 | SOU TEAS EXTENSION RECEIVED |